A patient with a clonal infection of Burkholderia pseudomallei had subpopulations with ceftazidime and amoxicillin-clavulanate susceptibilities that differed among the clinical specimens. Resistance was associated with a novel Cys69Tyr substitution in the Ambler class A ␤-lactamase. Susceptibility testing of multiple colony variants from different sites should be performed for patients with culture-confirmed melioidosis.
(F value), and cluster analysis was performed by the use of the unweighted-pair group method using average linkages and Bionumerics software, version 5.1 (Applied Maths, Sint-Martens-Latem, Belgium). Etests were used to measure MICs (AB Biodisk, Solna, Sweden), with B. pseudomallei NCTC 13178 and Pseudomonas aeruginosa ATCC 27853 used as controls. PCR amplification and sequencing of the complete class A (penA) and class D (oxa) ␤-lactamase genes were carried out (9, 17) . Sequences were then compared to those of B. pseudomallei strain K96243 (10) .
A total of five different isolates from the three specimens were studied (Table 1) . These showed two patterns of antibiotic susceptibility: intermediate susceptibility to ceftazidime and amoxicillin-clavulanate in the first pattern and ceftazidime resistance and amoxicillin-clavulanate susceptibility in the second pattern. All isolates were susceptible to imipenem, meropenem, chloramphenicol, and trimethoprim-sulfamethoxazole. There was a heterogenous population within the first stocked isolate, with ceftazidime-resistant white and yellow colonies as well as colonies that were intermediately susceptible. The resistant subpopulations had not been noted during primary processing of the specimens. Subsequent isolates, from sputum specimens, showed intermediate ceftazidime susceptibility, followed by ceftazidime resistance. PFGE using XbaI showed indistinguishable profiles for all patient isolates tested (data not shown). With SpeI, all showed the same 18-band profile, except for the 76161y isolate, which had one absent band between 216.9 and 244.4 kbp (F ϭ 0.97) (Fig. 1) . Thus, all isolates from this patient appear to represent the same strain (or a strain very closely related, in the case of 76161y), despite differences in antibiotic susceptibility and color.
All the isolates, regardless of the antibiotic susceptibility, had a silent mutation at position 750 of the oxa gene, resulting in the same class D ␤-lactamase amino acid sequence as that seen with strain K96243. Ceftazidime and amoxicillin-clavulanate resistance do not appear to be mediated by the class D ␤-lactamase (12, 17) .
All three ceftazidime-resistant isolates in this study had a single nucleotide change in penA, leading to a Cys69Tyr substitution, according to the Ambler numbering scheme (1). Situated next to the critical catalytic serine residue 70, residue 69 appears important in determining substrate specificity in SHV-1, another class A ␤-lactamase (8). Substitutions with Tyr, Phe, and Lys increased the hydrolysis of ceftazidime, while substitutions with Ile, Leu, and Val resulted in ␤-lactamase inhibitor resistance (8) . To date, the only reported mutation associated with ceftazidime resistance in B. pseudomallei is Pro167Ser in the class A ␤-lactamase, which is also located within a conserved motif of the catalytic site (9, 21). The mutation described in the present study appears to be novel in B. pseudomallei. Unchanged penA sequences were seen in all the ceftazidime-intermediate isolates in this study, and in a ceftazidime-resistant strain in another study (16) , suggesting the presence of other unidentified mechanisms of reduced susceptibility to ceftazidime. These include putative efflux pumps (13) and at least five other ␤-lactamases (10) which are present in the B. pseudomallei genome but have not yet been conclusively associated with ␤-lactam resistance.
The stocked isolate from the first specimen contained ceftazidime-intermediate and ceftazidime-resistant subpopulations, with the latter not being detected initially. We cannot exclude the possibility that the 76161w and 76161y colonies represent laboratory mutants or contaminants. However, ceftazidime resistance is rare in B. pseudomallei, having been reported to be present in just 0.5 to 0.7% of strains (5, 20) . Of 181 other strains tested in our laboratory with a MIC 50 of 2 g/ml and MIC 90 of 3 g/ml, none were resistant to ceftazidime (I. C. Sam, K. H. See, and S. D. Puthucheary, unpublished data). It is unlikely that ceftazidime resistance would arise within the ceftazidime-intermediate subpopulation in the absence of antibiotic pressure in the laboratory. Another possibility is contamination with ceftazidime-resistant isolate 3192; however, no yellow colonies were seen upon subculturing of isolate 3192. An alternative explanation is that resistant colonies 76161w and 76161y were present in low numbers in the initial blood culture and were undetected. B. pseudomallei appears to exhibit multiple phenotypes within a clonal population and can switch between them in response to the environment, resulting in variations in morphological appearance, intracellular replication, and persistence (2) . Highly resistant small-colony variants of B. pseudomallei can revert to the parental (larger) size phenotype and antibiotic susceptibility (7) . The clinical relevance of phenotypic switching is not known, but it may contribute to the propensity of B. pseudomallei infections to reoccur despite treatment.
For this case, we show that a single infectious clonal population of B. pseudomallei may contain subpopulations with differing ceftazidime and amoxicillin-clavulanate susceptibilities, that these susceptibilities are associated with a single nucleotide substitution in the penA gene, and that the relative proportions of these subpopulations may differ among specimens over time. Earlier treatment with ampicillin-sulbactam may have contributed to the initial development of reduced susceptibility to ␤-lactams; subsequent ceftazidime treatment ultimately led to selection of the ceftazidime-resistant subpopulation. Therefore, it is important for patients under treatment to have a detailed microbiological follow-up, including susceptibility testing of multiple colony variants from different sites.
Nucleotide sequence accession numbers. The penA sequences for isolates 76161 and 3192 and the oxa sequence for isolate 76161, representing the three different sequences seen in this case, were deposited in GenBank under accession numbers FJ147201 to FJ147203. 
